ETC
EVH icon

Exchange Traded Concepts’s Evolent Health EVH Stock Holding History

Exchange Traded Concepts’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-156
Closed -$2K – 1056
2020
Q3 		$2K Buy
+156
New +$1.83K ﹤0.01% 834

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Exchange Traded Concepts's EVH Position: Q4 2020 in Review

Exchange Traded Concepts sold out of Evolent Health (EVH) in Q4 2020, closing a stake of 156 shares — an estimated $2K sold.

Exchange Traded Concepts first reported a position in EVH in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 161 funds tracked by Wall St. Rank hold EVH as of Q4 2020.

  • Exchange Traded Concepts reported no remaining Evolent Health position as of Q4 2020 after selling out during the quarter.
  • Exchange Traded Concepts sold 156 Evolent Health shares in Q4 2020, an estimated $2K.
  • Exchange Traded Concepts first reported a position in Evolent Health in Q3 2020 and held it in 1 quarter.
  • Exchange Traded Concepts's Evolent Health position peaked at $2K in Q3 2020.
  • 161 funds tracked by Wall St. Rank held Evolent Health as of Q4 2020.

Based on Exchange Traded Concepts's 13F filing for Q4 2020, filed 19 Jan 2021.